Annual Research Review: Defining and treating pediatric treatment‐resistant depression
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Background: Adolescent major depressive disorder (MDD) is a significant health problem, associated with substantial morbidity, cost, and mortality. Depression is a significant risk factor for suicide, which is now the second leading cause of death in young people. Up to twenty per cent of adolescents will experience MDD before adulthood, and while a substantial proportion will improve with standard‐of‐care treatments (psychotherapy and medication), roughly one third will not. Methods: Here, we have reviewed the literature in order to discuss the concept of treatment‐resistant depression (TRD) in adolescence, examine risk factors, diagnostic difficulties, and challenges in evaluating symptom improvement, and providing guidance on how to define adequate medication and psychotherapy treatment trials. Results: We propose a staging model for adolescent TRD and review the treatment literature. The evidence base for first‐ and second‐line treatments primarily derives from four large pediatric clinical trials (TADS, TORDIA, ADAPT, and IMPACT). After two medications and a trial of evidence‐based psychotherapy have failed to alleviate depressive symptoms, the evidence becomes quite thin for subsequent treatments. Here, we review the evidence for the effectiveness of medication switches, medication augmentation, psychotherapy augmentation, and interventional treatments (i.e., transcranial magnetic stimulation, electroconvulsive therapy, and ketamine) for adolescent TRD. Comparisons are drawn to the adult TRD literature, and areas for future pediatric depression research are highlighted. Conclusions: As evidence is limited for treatments in this population, a careful consideration of the known risks and side effects of escalated treatments (e.g., mood stabilizers and atypical antipsychotics) is warranted and weighed against potential, but often untested, benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The adolescent brain and age-related behavioral manifestations
Spear, L. P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00014-2 · Cited by 5,433 · cited 1×
“For example, increased impulsivity and risk taking are features of this developmental period that are shared across mammalian species (Spear, 2000).”
BackgroundGlobal burden of disease in young people aged 10–24 years: a systematic analysis
Gore, F. M., Bloem, P. J., Patton, G. C., Ferguson, J., Joseph, V., Coffey, C., Sawyer, S. M., & Mathers, C. D. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60512-6 · Cited by 2,301 · cited 2×
“, 1988), and the overall financial burden of depression in society is considerable, estimated to be $210 billion in the United States in 2010 (Greenberg, Fournier, Sisitsky, Pike, & Kessler, 2015), and pediatric neuropsychiatric disorders are considered the most substantial contributor to the worldwide burden of disea…”
BackgroundThe number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885 · cited 1×
“The NNT is the inverse of the absolute risk reduction and represents the number of patients that would need to receive the medication in order to obtain one antidepressant response compared to receiving placebo, with lower NNTs implying more effective interventions (Cook & Sackett, 1995).”
BackgroundThe Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779
Nanni, V., Uher, R., & Danese, A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020335 · Cited by 1,480
Mental Health in Lesbian, Gay, Bisexual, and Transgender (LGBT) Youth
Russell, S. T., & Fish, J. N. (2016) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-021815-093153 · Cited by 1,276
Mental Health, Educational, and Social Role Outcomes of Adolescents With Depression
Fergusson, D. M., & Woodward, L. J. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.3.225 · Cited by 1,112 · cited 1×
“…depression is associated with increased risk of poor social and academic functioning, early pregnancy, physical illness, and substance abuse (Fergusson & Woodward, 2002; Keenan-Miller, Hammen, & Brennan, 2007; Weissman et al., 1999), and depression that begins in adolescence is associated…”
BackgroundBridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086
Self-citationBirmaher, B., & Brent, D. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318145ae1c · Cited by 1,056
Self-citationSuicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) · BMJ · doi:10.1136/bmj.f3646 · Cited by 920
Weisz, J. R., Kuppens, S., Ng, M. Y., Eckshtain, D., Ugueto, A. M., Vaughn-Coaxum, R., Jensen-Doss, A., Hawley, K. M., Krumholz Marchette, L. S., Chu, B. C., et al. (2017) · American Psychologist · doi:10.1037/a0040360 · Cited by 862 · cited 5×
“For instance, the benefits in terms of effect size of evidence-based psychotherapy (Weisz et al., 2017) are higher for pediatric anxiety disorders than depression; thus, it may often be advisable to start psychotherapy targeting particularly impairing anxiety symptoms with target CBT exercises.”
BackgroundResultInfluentialSystematic Review and Meta-Analysis: Adolescent Depression and Long-Term Psychosocial Outcomes
Clayborne, Z. M., Varin, M., & Colman, I. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.07.896 · Cited by 787
Cipriani, A., Zhou, X., Del Giovane, C., Hetrick, S. E., Qin, B., Whittington, C., Coghill, D., Zhang, Y., Hazell, P., Leucht, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30385-3 · Cited by 734
Wilkinson, S. T., Ballard, E. D., Bloch, M. H., Mathew, S. J., Murrough, J. W., Feder, A., Sos, P., Wang, G., Zarate, C. A., & Sanacora, G. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17040472 · Cited by 696
Self-citationCanuso, C. M., Singh, J. B., Fedgchin, M., Alphs, L., Lane, R., Lim, P., Pinter, C., Hough, D., Sanacora, G., Manji, H., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17060720 · Cited by 676
Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression.
Newport, D. J., Carpenter, L. L., McDonald, W. M., Potash, J. B., Tohen, M., Nemeroff, C. B., & The APA Council of Research Task Force on Novel Biomarkers and Treatments (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040465 · Cited by 598 · cited 2×
“5 mg/kg over 40 min) in adults with treatment-refractory depression suggests that more than half of adults with MDD who are given a single ketamine infusion experience a greater than 50% reduction in depressive symptoms within 1 day (Newport et al., 2015).”
BackgroundInfluentialSingh, J. B., Fedgchin, M., Daly, E. J., De Boer, P., Cooper, K., Lim, P., Pinter, C., Murrough, J. W., Sanacora, G., Shelton, R. C., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16010037 · Cited by 525 · cited 2×
“Although the benefits of ketamine typically dissipate within a week or two, further research has suggested that when ketamine is given twice a week for several weeks, it can induce a prolonged treatment response (Singh et al., 2016).”
BackgroundEvidence Base Update of Psychosocial Treatments for Child and Adolescent Depression
Weersing, V. R., Jeffreys, M., Do, M.-C. T., Schwartz, K. T. G., & Bolano, C. (2017) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2016.1220310 · Cited by 505 · cited 3×
“Despite being more thoroughly studied than other specialized psychotherapies, CBT and interpersonal psychotherapy for adolescents (IPT-A) have been demonstrated equally (Weersing, Jeffreys, Do, Schwartz, & Bolano, 2017) or near equally (Eckshtain et al., 2019) clinically effective, and the IMPACT trial demonstrated eq…”
BackgroundAdult Outcomes of Youth Irritability: A 20-Year Prospective Community-Based Study
Stringaris, A., Cohen, P., Pine, D. S., & Leibenluft, E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08121849 · Cited by 486
Self-citationMcMakin, D. L., Olino, T. M., Porta, G., Dietz, L. J., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Ryan, N. D., Birmaher, B., et al. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.01.011 · Cited by 448 · cited 1×
“Psychiatric risk factors for poor therapeutic responses include anhedonia (McMakin et al., 2012) and subsyndromal manic symptoms (Maalouf et al., 2012); the use of the sleep aid trazodone has also been associated with poorer SSRI responsiveness in clinical trials, especially when co-prescribed with…”
BackgroundAdjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Sarris, J., Murphy, J., Mischoulon, D., Papakostas, G. I., Fava, M., Berk, M., & Ng, C. H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091228 · Cited by 436 · cited 1×
“Similarly, folic acid supplementation has been studied in multiple trials of adult depression with meta-analyses suggesting minimal-to-no benefit compared with placebo (Almeida, Ford, & Flicker, 2015; Roberts, Carter, & Young, 2018; Sarris et al., 2016; Schefft, Kilarski, Bschor, & Kohler, 2017).”
BackgroundMutz, J., Vipulananthan, V., Carter, B., Hurlemann, R., Fu, C. H. Y., & Young, A. H. (2019) · BMJ · doi:10.1136/bmj.l1079 · Cited by 427 · cited 1×
“…ECT trials suggests strong evidence of efficacy for ECT compared to sham treatments with an odds ratio of treatment response of 8.91 (95% CI: 2.57–30.91) and effect size of 0.90 (95% CI: 0.52– 1.27) compared to sham treatments (Kho, van Vreeswijk, Simpson, & Zwinderman, 2003; Mutz et al., 2019).”
ResultInfluentialFact or fiction: Diagnosing borderline personality disorder in adolescents
Miller, A. L., Muehlenkamp, J. J., & Jacobson, C. M. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2008.02.004 · Cited by 375
Burleson Daviss, W., Birmaher, B., Melhem, N. A., Axelson, D. A., Michaels, S. M., & Brent, D. A. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2006.01646.x · Cited by 370
Self-citationSzegedi, A., Jansen, W. T., van Willigenburg, A. P. P., van der Meulen, E., Stassen, H. H., & Thase, M. E. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.07m03780 · Cited by 341 · cited 1×
“Previous trials in adult depression have also strongly associated early SSRI response with improved treatment response (Szegedi et al., 2009).”
ResultGuo, T., Xiang, Y.-T., Xiao, L., Hu, C.-Q., Chiu, H. F. K., Ungvari, G. S., Correll, C. U., Lai, K. Y. C., Feng, L., Geng, Y., et al. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14050652 · Cited by 308 · cited 3×
“Recent data in adult psychiatry suggest that implementing standardized instruments and measurement-based care into the clinic is both feasible, and leads to better outcomes in MDD compared with standard care (Guo et al., 2015).”
BackgroundInfluentialCOHEN, J. A., MANNARINO, A. P., PEREL, J. M., & STARON, V. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180547105 · Cited by 300
A meta-analysis of electroconvulsive therapy efficacy in depression
Kho, K. H., van Vreeswijk, M. F., Simpson, S., & Zwinderman, A. H. (2003) · The Journal of ECT · doi:10.1097/00124509-200309000-00005 · Cited by 265
Goodyer, I. M., Reynolds, S., Barrett, B., Byford, S., Dubicka, B., Hill, J., Holland, F., Kelvin, R., Midgley, N., Roberts, C., et al. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30378-9 · Cited by 259 · cited 10×
“While CBT has been the best-studied specialized psychotherapy in adolescent populations, it is equally effective to IPT (Weersing et al., 2017), STPP, and a brief psychosocial intervention (Goodyer et al., 2017).”
BackgroundMethodInfluentialBridge, J. A., Birmaher, B., Iyengar, S., Barbe, R. P., & Brent, D. A. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020247 · Cited by 256
Self-citationAdaptive Functioning and Psychiatric Symptoms in Adolescents With Borderline Personality Disorder
Chanen, A. M., Jovev, M., & Jackson, H. J. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0217 · Cited by 241
Beijers, L., Wardenaar, K. J., van Loo, H. M., & Schoevers, R. A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0385-5 · Cited by 240
Fonagy, P., Rost, F., Carlyle, J., McPherson, S., Thomas, R., Pasco Fearon, R. M., Goldberg, D., & Taylor, D. (2015) · World Psychiatry · doi:10.1002/wps.20267 · Cited by 237 · cited 1×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript received psychoanalytic therapy (Fonagy et al., 2015).”
MethodChildhood and Adolescent Depression: Child-report versus Parent-report Information
MORETTI, M. M., FINE, S., HALEY, G., & MARRIAGE, K. (1985) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)61090-6 · Cited by 232
Meta-analysis: 13-year follow-up of psychotherapy effects on youth depression
Eckshtain, D., Kuppens, S., Ugueto, A., Ng, M. Y., Vaughn-Coaxum, R., Corteselli, K., & Weisz, J. R. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.04.002 · Cited by 224 · cited 1×
“Despite being more thoroughly studied than other specialized psychotherapies, CBT and interpersonal psychotherapy for adolescents (IPT-A) have been demonstrated equally (Weersing, Jeffreys, Do, Schwartz, & Bolano, 2017) or near equally (Eckshtain et al., 2019) clinically effective, and the IMPACT trial demonstrated eq…”
BackgroundTreatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes
Emslie, G. J., Mayes, T., Porta, G., Vitiello, B., Clarke, G., Wagner, K. D., Asarnow, J. R., Spirito, A., Birmaher, B., Ryan, N., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09040552 · Cited by 217 · cited 6×
“…of 6-month TORDIA outcomes suggested a potential benefit of earlier augmentation with an atypical antipsychotic or mood stabilizer, numbers were small (5 of 10 subjects improved with augmentation vs. 27 of 153 improved without; Emslie et al., 2010) and more pediatric evidence is sorely needed.”
BackgroundResultInfluentialSelf-citationStaging methods for treatment resistant depression. A systematic review
Ruhé, H. G., van Rooijen, G., Spijker, J., Peeters, F. P. M. L., & Schene, A. H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.02.020 · Cited by 210
Zhou, X., Ravindran, A. V., Qin, B., Del Giovane, C., Li, Q., Bauer, M., Liu, Y., Fang, Y., da Silva, T., Zhang, Y., et al. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14r09204 · Cited by 189
Strawn, J. R., Welge, J. A., Wehry, A. M., Keeshin, B., & Rynn, M. A. (2015) · Depression and Anxiety · doi:10.1002/da.22329 · Cited by 183
Tricyclic drugs for depression in children and adolescents
Hazell, P., O'Connell, D., Heathcote, D., & Henry, D. A. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002317 · Cited by 167
Cognitive behavioral therapy for panic disorder and comorbidity: More of the same or less of more?
Craske, M. G., Farchione, T. J., Allen, L. B., Barrios, V., Stoyanova, M., & Rose, R. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2006.09.006 · Cited by 140
Brent, D., Melhem, N., Ferrell, R., Emslie, G., Wagner, K. D., Ryan, N., Vitiello, B., Birmaher, B., Mayes, T., Zelazny, J., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040576 · Cited by 138 · cited 3×
“Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study.”
BackgroundSelf-citationVenlafaxine ER for the Treatment of Pediatric Subjects With Depression
EMSLIE, G. J., FINDLING, R. L., YEUNG, P. P., KUNZ, N. R., & LI, Y. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31802f5f03 · Cited by 135
Lee, E. E., Della Selva, M. P., Liu, A., & Himelhoch, S. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.01.003 · Cited by 124
High-frequency repetitive TMS for suicidal ideation in adolescents with depression
Croarkin, P. E., Nakonezny, P. A., Deng, Z.-D., Romanowicz, M., Voort, J. L. V., Camsari, D. D., Schak, K. M., Port, J. D., & Lewis, C. P. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.048 · Cited by 95
Offidani, E., Fava, G. A., Tomba, E., & Baldessarini, R. J. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000345316 · Cited by 94
Dobson, E. T., Bloch, M. H., & Strawn, J. R. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17r12064 · Cited by 89
Self-citationThe Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis
McIntyre, R. S., Lee, Y., Zhou, A. J., Rosenblat, J. D., Peters, E. M., Lam, R. W., Kennedy, S. H., Rong, C., & Jerrell, J. M. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000723 · Cited by 75
Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review
Bokma, W. A., Wetzer, G. A. A. M., Gehrels, J. B., Penninx, B. W. J. H., Batelaan, N. M., & Balkom, A. L. J. M. (2019) · Depression and Anxiety · doi:10.1002/da.22895 · Cited by 58 · cited 1×
“While multiple strategies for producing a consensus definition of treatment resistance in psychiatric disorders exist (Bokma et al., 2019), the definitions provided in Box 1 mirror the adult depression literature on this topic but are adapted for the reduced pediatric depression evidence base.”
BackgroundLam, R. W., Parikh, S. V., Ramasubbu, R., Michalak, E. E., Tam, E. M., Axler, A., Yatham, L. N., Kennedy, S. H., & Manjunath, C. V. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.125237 · Cited by 56 · cited 1×
“The efficacy of treatments in clinical trials, however, does not always align between clinical and functional outcomes, as patients who show clinical symptom reduction do not always show improvements in functional outcomes, and vice versa (Lam et al., 2013).”
BackgroundBrief psychotherapy for maternal depression: impact on mothers and children
Swartz, H. A., Cyranowski, J. M., Cheng, Y., Zuckoff, A., Brent, D. A., Markowitz, J. C., Martin, S., Amole, M. C., Ritchey, F., & Frank, E. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.04.003 · Cited by 46 · cited 2×
“, 2013), parental depression (Swartz et al., 2016; Weissman et al., 2006), being bullied (van Geel, Vedder, & Tanilon, 2014), and being a member of a sexual or gender minority group (Russell & Fish, 2016).”
BackgroundSelf-citationMagavi, L. R., Reti, I. M., & Vasa, R. A. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1300574 · Cited by 41
Heiligenstein, J. H., Hoog, S. L., Wagner, K. D., Findling, R. L., Galil, N., Kaplan, S., Busner, J., Nilsson, M. E., Brown, E. B., & Jacobson, J. G. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.207 · Cited by 39 · cited 2×
“Additionally, a previous trial that examined 29 children who had not responded adequately to 20 mg of fluoxetine at 9 weeks of treatment suggested that raising the dose of fluoxetine to 40–60 mg (response rate 71%) was more effective than maintaining the dose at 20 mg (response rate 36%; Heiligenstein et al., 2006).”
BackgroundLithium Treatment in Children and Adolescents
Duffy, A., & Grof, P. (2018) · Pharmacopsychiatry · doi:10.1055/a-0575-4179 · Cited by 22 · cited 1×
“Similarly, there are no randomized, placebo-controlled trials examining the efficacy of lithium as a monotherapy or augmentation strategy in pediatric depression (Duffy & Grof, 2018).”
BackgroundRemissions in Maternal Depression and Child Psychopathology: A STAR*D-Child Report
Weissman, M. M., Pilowsky, D. J., Wickramaratne, P. J., Talati, A., Wisniewski, S. R., Fava, M., Hughes, C. W., Garber, J., Malloy, E., King, C. A., et al. (2006) · JAMA · doi:10.1001/jama.295.12.1389 · Cited by 9
Cited by
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 768
Lu, B., Lin, L., & Su, X. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.074 · Cited by 289
Miller, L., & Campo, J. V. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2033475 · Cited by 199
Murphy, S. E., Capitão, L. P., Giles, S. L. C., Cowen, P. J., Stringaris, A., & Harmer, C. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00154-1 · Cited by 112
The impact of adverse childhood experiences on adult depression severity and treatment outcomes
Giampetruzzi, E., Tan, A. C., LoPilato, A., Kitay, B., Riva Posse, P., McDonald, W. M., Hermida, A. P., Crowell, A., & Hershenberg, R. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.071 · Cited by 55
Metadata
- Authors
- Dwyer, J. B., Stringaris, A., Brent, D. A., & Bloch, M. H.
- Venue
- Journal of Child Psychology and Psychiatry
- Publisher
- Wiley
- Published
- 2020-02-04
- Volume
- 61
- Issue
- 3
- Pages
- 312-332
- ISSN
- 0021-9630 (ISSN-L)
- 1469-7610
- OpenAlex
- W3004998718
- Cited by
- 148
- References
- 57
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.